• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    AngioDynamics, Inc. - Common Stock (NQ: ANGO )

    8.890 +0.310 (+3.61%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about AngioDynamics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
    From AngioDynamics, Inc.
    Via Business Wire
    In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics
    Via Benzinga
    AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
    From AngioDynamics, Inc.
    Via Business Wire
    4 Analysts Assess AngioDynamics: What You Need To Know
    Via Benzinga
    AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
    From AngioDynamics, Inc.
    Via Business Wire
    3 Stocks Insiders Are Buying Heavily In October 2024, And Why
    Should investors add these stocks on their watchlist? Insider buys suggest so. 
    Via Talk Markets
    Nasdaq Moves Lower; Levi Strauss Shares Slide
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Jumps Over 4%; US Services PMI Revised Lower
    Via Benzinga
    Exposures Fossil Fuels
    Why AngioDynamics Stock Is Crashing Today
    Investors didn't like the medical technology company's fiscal 2025 Q1 update. 
    Via The Motley Fool
    AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
    Via Benzinga
    US Stocks Staring At Another Weak Open As Traders Await Key Jobs Report; Sentiment Wavers As Oil Extends Surge Amid Middle East Tensions
    Sentiment continues to be cautious as traders play the “wait-and-watch” game until they see off Friday’s non-farm payroll data. The index futures traded moderately lower early Thursday. 
    Via Benzinga
    AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
    From AngioDynamics, Inc.
    Via Business Wire
    Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings
    Via Benzinga
    S&P Settles Slightly Higher Despite Middle East Concerns: Fear Index Remains In 'Greed' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
    Via Benzinga
    AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
    From AngioDynamics, Inc.
    Via Business Wire
    PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    AngioDynamics to Participate in Upcoming Investor Conferences
    From AngioDynamics, Inc.
    Via Business Wire
    Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
    Via Benzinga
    Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
    AngioDynamics reported a Q4 2024 adjusted EPS loss of $(0.05), beating the consensus of $(0.16). Sales rose 1.9% to $79.1 million, driven by strong performance in the Med Tech segment. The company... 
    Via Benzinga
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024
    ANGO stock results show that AngioDynamics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
    Via InvestorPlace
    AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
    From AngioDynamics, Inc.
    Via Business Wire
    AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
    From AngioDynamics, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.